AI Retinal Diagnostics Firm Leben Care Secures Angel Funding to Enhance Product and Expand Operations

On July 29, 2019, VCBeat (WeChat ID: vcbeat) learned that Leben Care Technologies, a Singapore-based startup specializing in retinal diagnostics, had secured angel funding from Inflection Point (IP) Ventures.

Leben Care stated that it would use the funds to upgrade its products and expand its sales and marketing teams. Leben Care did not disclose the specific amount of capital raised.

Leben Care was founded in 2016 by Nitin Srivastava, Theenathayalan Parthasarathy, and Imran Akthar. Its flagship product, Netra.AI, leverages AI algorithms to automatically analyze retinal images for the prevention of blindness. The platform facilitates basic screening with minimal expert intervention.

Currently, Leben Care operates in India, Japan, Singapore, Africa, and Australia through a business model that collaborates with distributors and eye care centers.

Nitin Srivastava, Co-founder and CEO of Leben Care, stated: “Our goal is to use AI to prevent avoidable blindness, and we hope to make this technology available to millions of people who have difficulty accessing basic screening. Our Netra.AI platform aims to become the go-to destination for all ophthalmology-related AI solutions.”

Netra.AI Platform (Comprehensive Ophthalmology Platform) provides valuable, automated clinical insights into the retina, vasculature, and lesions, assisting primary care providers in supplying supporting information to ophthalmologists. Retina specialists and other healthcare professionals can also leverage the platform for deep learning.

Mitesh Shah, Co-Founder of IP Ventures, stated in a press release, “Leben Care has a competent team and maintains strategic partnerships with several outstanding companies. We are delighted to collaborate with them.”

Leben Care Technologies is an artificial intelligence (AI) healthcare company dedicated to improving the quality of diagnosis and care in the life sciences sector. Founded in late 2016, Leben Care provides users with automated medical image analysis algorithms, striving to enhance the accessibility and quality of diagnostics in the life sciences field.

Inflection Point VenturesFounded in2017year, isCXO Geniesub-project, composed of the Chief Financial Officer and senior professionals. The company is comprised of individuals fromMyntra、BookMyShowandGrofersof startups9Founded by renowned Chief Financial Officers and finance professionals.Inflection Point VenturesAims to drive exponential value creation by connecting a diverse investor community with carefully curated startups through India’s most accessible and efficient network.

IPV is an early-stage investment platform that provides monetary and non-monetary services to startups. It currently boasts a network of over 250 angel investors, with its community expanding beyond C-suite executives to include high-net-worth individuals (HNIs) from diverse backgrounds, professions, and fields of expertise. IPV caters to investors in India and overseas, providing them with access to startup opportunities and deals.

(Compiled by Tian Shuhang)